Osmotica Pharmaceutical Corp.

GA · United States · Reporting entity ID 100000016250

Total reported 2019–2025

$727K

#1,432 of 2,960 reporting companies — 0% of all reported industry payments

$148K in general payments across 128 records, plus $578K in research funding across 183 records.

How it breaks down

General payments $148,498

Research funding $578,392

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.